Here’s Why Qualcomm Shares Are Moving

Qualcomm Inc (NASDAQ: QCOM) shares are trading higher by 1.2% to $125.54 going into the close of Thursday's session.

Qualcomm Inc (NASDAQ:QCOM) shares are trading higher by 1.2% to $125.54 going into the close of Thursday’s session. Shares of semiconductor and chip stocks are trading higher following strong fourth-quarter financial results from Lam Research.

What Happened With Lam Research?

Lam Research reported quarterly adjusted earnings of $5.98 per share, surpassing the analyst consensus estimate of $5.07 by 17.95%. However, this represents a 32.28% decrease compared to earnings of $8.83 per share from the same period last year.

The company reported quarterly sales of $3.21 billion, exceeding the analyst consensus estimate of $3.13 billion by 2.46%. Nevertheless, this reflects a 30.82% decrease compared to sales of $4.64 billion in the same period last year.

Lam Research expects its adjusted EPS for the first-quarter to be approximately $6.05, with a possible range of plus or minus $0.75. Additionally, the company anticipates sales of around $3.4 billion, with a potential variation of plus or minus $300 million.

Following the earnings print, LRCX received a number of analyst rating updates.

According to data from Benzinga Pro, QCOM has a 52-week high of $152.91 and a 52-week low of $101.47.

Total
0
Shares
Related Posts
Read More

Novartis Announced Plans to Petition the U.S. Supreme Court to Uphold Validity of the Gilenya Dosing Regimen Patent

Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied its petition to rehear the negative decision regarding the validity of US Patent No. 9,187,405, covering a dosing regimen for 0.5mg Gilenya. Novartis plans to file a petition seeking further review of the CAFC's decision with the US Supreme Court.

NVS